Abstract
We report 11 critically-ill burn patients treated with cefiderocol for carbapenem-resistant
Acinetobacter baumannii infections. Clinical success was achieved in 36% and complicated by treatment-emergent resistance and inter-patient transmission of cefiderocol-resistant
A. baumannii between patients. Resistant isolates harbored disrupted
pirA and piuA gen es that were not disrupted among susceptible isolates.
No comments:
Post a Comment